INTRODUCTION
============

Epilepsy is one of the most common and heterogeneous neurological disorders, with an estimated prevalence of 40 to 50 million patients worldwide \[[@R1]\]. The incidence of epilepsy is particularly high in children under 5 years of age and in individuals older than 65 years \[[@R2],[@R3]\]. About one fourth of all cases develop before the age of five \[[@R4]\].

Epilepsy or epileptic condition is defined by a state of recurrent, spontaneous (unprovoked) seizures, which can be convulsive or non-convulsive episodes. It is characterized by synchronized abnormal electrical activity arising from a group of cerebral neurons \[[@R3],[@R5],[@R6]\].

Nowadays, the increasing attention is paid to the possible connection between oxidative stress that results in disturbance of physiological signalling roles of Ca^2+^ which is associated with the increased production of free radicals, mitochondrial dysfunction, cell damage and consequently epilepsy.

Mitochondria are well known as the main source of the cell\'s adenosine triphosphate (ATP). In numerous cell types they also serve as Ca^2+^ buffer. As a consequence of Ca^2+^influenced ATP production in the mitochondria, reactive oxygen species (ROS) are generated. It is supposed that Ca^2+^ ions, as well as ROS, under physiological conditions work as positive effectors and cellular signalling molecules within mitochondrial signalling pathways, while their overload can lead to mitochondrial dysfunction, oxidative stress and cell damage. Neuronal dysfunction or death could serve as the propagating factor that may lead to the epileptic condition.

This review is focused on acquired epilepsy and comprehensively examines the evidence for the initial role of subtle disturbance in Ca^2+^ and ROS cellular balance in epileptogenesis. Furthermore, the influence of anticonvulsant therapy on endogenous ability to prevent oxidative stress will be reviewed.

ETIOLOGY OF EPILEPSY
====================

Epilepsy can be either idiopathic or symptomatic. It is estimated that up to 50% of epilepsy cases are symptomatic or acquired, therefore associated with a previous neurological insult \[[@R7]\]. Acquired form of epilepsy does not have a genetic link and becomes more common as people age. It is more widespread than genetic or idiopathic form. Idiopathic epilepsy is mainly due to genetic causes or developmental central nervous system (CNS) disorders and malformations, that most often affect mitochondrial or ion channel function. There are many genetic factors that contribute to the increased neuronal excitability present in most idiopathic epilepsies. Any mutation or defect in mitochondrial respiratory chain complexes, synapses, and neurotransmitter receptors or in the voltage and ligand channels may alter brain excitability and cause epileptic seizures. Epilepsy is in most cases multifactorial. It often arises in part from both, the genetic and the acquired factors. Aetiology varies among various age groups, patient groups and geographical locations. In general, congenital and perinatal conditions are the most common causes of early childhood epilepsy onset; while in adults, epilepsy is more likely to be due to external non-genetic causes. However, this distinction is by no means absolute.

The epilepsies are normally divided into 'early' (i.e. seizures occurring within a week of the insult) and 'late' (i.e. chronic epilepsy developing later). Between the injury and the onset of late epilepsy, there is normally a 'latent period'. During this period, most likely epileptogenic processes are developing, which raises the possibility for neuroprotective interventions to prevent later epilepsy.

THE DEVELOPMENT PHASES OF SYMPTOMATIC EPILEPSY
==============================================

It is generally accepted that development processes of acquired epilepsy occur in three major phases: the acute phase - injury, the latency phase - epileptogenesis, and finally the phase of spontaneous recurrent seizures - chronic epilepsy \[[@R8]\].

The Acute Phase -- Injury
-------------------------

Epileptogenesis in acquired epilepsy can be initiated by a number of types of brain lesions and these numerous aetiologies may vary with age. Illnesses in the form of tumours, infections, status epilepticus, childhood febrile seizures, stroke, hypoxia and neurodegenerative diseases, increase the incidence of acquired epilepsy. Furthermore, status epilepticus, stroke, and traumatic brain injury are considered as the three major causes of brain injuries and acquired epilepsy \[[@R7]\].

Sometimes CNS insults are associated with immediate seizures in the acute setting, but since epileptogenesis phase is required, this does not necessarily mean that it will lead to acquired epilepsy \[[@R8]\].

The Latent Phase - Epileptogenesis
----------------------------------

The process whereby an initial central nervous system insult leads to the development of the epileptic condition is referred to as epileptogenesis. This transition processes may take years or even decades after the initial insult. This might suggest that a progression of changes in response to the initial insult is critical to the development of the epileptic condition \[[@R3],[@R9]\]. Furthermore, epilepsy is usually not a static condition, but evolves over the lifespan \[[@R10]\].

Despite enormous progress in neuroscience in the last few decades, so far, the exact mechanism of epileptogenesis is not known \[[@R11]\]. Among the events that occur in response to the initial insult, neuronal cell death has received significant attention as the propagating factor that may lead to the epileptic condition. However, its actual role in epileptogenesis is still controversial. Neuronal cell death can be presented either as a consequence of epileptic seizure only, or both, a cause and a consequence, as proposed by the increasing evidence \[[@R3],[@R9]\].

Seizures can result in neuronal cell death through dynamic processes that might include genetic factors, excitotoxicity induced mitochondrial dysfunction, altered cytokine levels, oxidative stress, and changes in plasticity or activation of some late cell death pathways \[[@R12]-[@R14]\]. It was suggested that oxidative damage and consequently neuronal cell death have common pathogenic processes that can contribute to epileptogenesis and to initiation and propagation of spontaneous recurrent epileptic seizures \[[@R15]\].

Initial brain insult causes a cascade of structural, physiological, and biochemical changes, such as altered cerebral blood ﬂow and vasoregulation, disruption of the blood brain barrier, increased intracranial pressure, focal or diffuse ischemic haemorrhage, inﬂammation, necrosis and disruption of ﬁber tracts and blood vessels \[[@R16]\]. In posttraumatic epilepsy, for example, it was suggested that after intracranial haemorrhage, red blood cells break down and release haemoglobin (Hb) and iron ions. Consequently ROS are generated by iron- or Hb-mediated reactions \[[@R16],[@R17]\]. Increased production of ROS induces a cascade of cellular and molecular changes that might lead to hyperexcitability of neurons or to neuronal death \[[@R18]\]. The hypothesis of neuronal death caused or propagated epilepsy is further supported by the fact that surgical removal of a damaged hippocampus improves the condition of epilepsy patients \[[@R19]\]. Therefore nowadays, accumulating evidence suggests that neuronal cell death may be both a cause and a consequence of epileptic seizures \[[@R3]\].

The Phase of Spontaneous Recurrent Seizures - Chronic Epilepsy
--------------------------------------------------------------

The major mystery that still has to be explained is how the initial injury can produce these long-term changes in neuronal excitability that lead to spontaneous recurrent seizures of acquired epilepsy.

As discussed above, brain insult results in increased oxidation of cellular macromolecules prior to the death of vulnerable neurons. At this stage endogenous antioxidant defence system prevents seizure-induced neuronal death \[[@R20]-[@R22]\]. Oxidative stress has been suggested to be a significant consequence of excitotoxicity that plays a critical role in epileptic brain damage. Excessive ROS production leads to increased intracellular concentration of Ca^2+^ ions through mechanisms discussed in the following section. Ca^2+^ overload is involved in seizure-induced neuronal death, as well as in necrosis and apoptosis \[[@R23]\].

It is suggested, that during the injury phase of seizures, Ca^2+^ concentration may reach high levels. If concentrations are moderately elevated, neurons are subjected to long lasting neuroplasticity changes. However, in case of very high Ca^2+^ concentrations, cell death is induced. Ca^2+^ concentration remains elevated during the latent phase. Therefore, many second messenger effects, which can produce long-lasting plasticity changes in these neurons, are initiated \[[@R7]\]. High Ca^2+^ concentration in the epileptic neurons remains elevated also during the chronic epilepsy phase, and plays a role in maintenance of the spontaneous recurrent seizures. It can alter GABA~A~ receptor recycling which can serve as a possible mechanism for the effect of Ca^2+^ on altering neuronal excitability \[[@R24]\]. Furthermore, increased intracellular Ca^2+^concentration can effect numerous cell physiological processes, including gene transcription, protein expression and turnover, neurogenesis, neuronal sprouting, and many others \[[@R25]\].

SIGNALLING ROLES OF Ca^2+^ AND ROS
==================================

ROS play an important role in cell signalling \[[@R26]\]. Mitochondria are important players in maintaining cell Ca^2+^ homeostasis and serve as Ca^2+^ buffer. Physiological increases in mitochondrial Ca^2+^ lead to the activation of tricarboxylic acid (TCA) cycle enzymes including isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, maleate dehydrogenase, as well as succinate dehydrogenase \[[@R27]\]. Their activation results in increased concentrations of reduced substrates for oxidative phosphorylation (NADH and FADH~2~). Therefore, physiological increase in mitochondrial Ca^2+^ results in enhanced respiratory chain activity, increased proton pumping and consequently generation of ROS. The reciprocal interaction between Ca^2+^ modulated ROS production and ROS modulated Ca^2+^ signalling underlies the concept of ROS and Ca^2+^ crosstalk. Ca^2+^ can alter ROS production by simply increasing metabolic rate *via*TCA cycle stimulation \[[@R28]\]. Moreover, Ca^2+^ can activate nitric oxide synthase (NOS) and generate nitric oxide. Nitric oxide has been shown to inhibit complex IV, which can in turn lead to ROS production at the Q~0~ site of complex III \[[@R29]\]. Nitric oxide has also been shown to elicit synaptic glutamate release and therefore contribute to further excitotoxicity in neighbouring cells \[[@R29]\]. Hence, Ca^2+^ may stimulate oxidative phosphorylation electron flux on one side, and partial inhibition of the electron transport chain on the other. Inhibition of electron transport chain could lead to an increased possibility of electron slippage to oxygen.

Just as Ca^2+^ plays a role in the production of ROS, cellular redox state can significantly modulate Ca^2+^ signalling. Moreover, protein redox state modulates many cellular processes. Changes in structure caused by oxidizing amino acid residues can change the activity of enzymes and ion transporters \[[@R30]\]. In the context of Ca^2+^ signalling, redox state and ROS can stimulate, as well as inhibit Ca^2+^ channels/pumps/exchangers, generally increasing Ca^2+^ channel activity and inhibiting Ca^2+^ pumps \[[@R31]\]. Precisely, ROS can directly, or indirectly through changes in cell redox homeostasis, oxidize redox-sensing thiol groups on the ryanodine receptors leading to channel stimulation. Ryanodine receptors are the primary Ca^2+^ release channel involved in the sarcoplasmic Ca^2+^ release. Furthermore, ROS derived stimulation of inositol-1,4,5-triphosphate receptor channels and inhibition of sarco/endoplasmic reticulum ATPase and plasma membrane Ca^2+^ ATPase, results in increased mitochondrial Ca^2+^concentrations. Inositol-1,4,5-triphosphate receptor channels are the primary Ca^2+^endoplasmic reticulum release channels, while sarco/endoplasmic reticulum and plasma membrane Ca^2+^ ATPase are Ca^2+^ re-uptake pumps. Furthermore, there is also an important plasma membrane Na^+^/Ca^2+^ exchanger \[[@R31]\]. Its function is also modulated by oxidation. Currently, its exact role is still unknown, as ROS can both, stimulate and decrease its activity.

The stimulation of mitochondrial Ca^2+^ signals by ROS and increased ROS generation resulting from increased mitochondrial Ca^2+^ can lead to a positive feedback loop. So Ca^2+^ can pose both, a physiological and a pathological effect of mitochondrial function.

Oxidative Stress as a Disturbance of Physiological Signalling Roles of Ca^2+^ and Free Radicals
-----------------------------------------------------------------------------------------------

Oxidative stress is defined as an imbalance between the production of ROS on one side and endogenous antioxidant and repair capacity on the other, in favour of the former \[[@R32]\].

As Ca^2+^ buffer, mitochondria can suffer Ca^2+^ overload, which may lead to free radical production. It is thought, that a delicate balance exists between moderate ROS production to modulate physiological signalling, and overproduction of ROS resulting from mitochondrial Ca^2+^ overload that ultimately leads to oxidative stress, cellular damage, and eventually cell death. Ca^2+^overload triggers the opening of the mitochondrial permeability transition (MPT) pores which is linked to apoptosis *via*the mitochondrial pathway or necrosis due to mitochondrial damage \[[@R33]\]. This confirms the complex interdependence between mitochondrial energy production, Ca^2+^ uptake, ROS generation, ROS neutralisation, and redox signalling. While physiological increases in mitochondrial Ca^2+^ are beneficial for metabolism, overload is detrimental to mitochondrial function and can become pathological.

Possible Role of Free Radical Homeostasis Disturbance in Epileptogenesis
------------------------------------------------------------------------

The role of free radical homeostasis in neuronal disorders is of major interest, since cells in the CNS are particularly vulnerable to the harmful effects of ROS and reactive nitrogen species (RNS). In addition, antioxidant defence mechanisms in CNS are particularly poor. This is especially important because the brain is rich in mitochondria and is characterised by high aerobic metabolic activity, high oxygen consumption, high ratio of membrane surface area to cytoplasmic volume, high concentration of polyunsaturated fatty acids, and a neuronal network vulnerable to disruption \[[@R34]\]. The brain is also rich in iron, and brain damage releases iron ions capable of catalyzing free radical reactions \[[@R35]\]. Furthermore, superoxide radicals can arise also from the auto-oxidation of catecholamines and in the cytoplasm by enzymes, such as xanthine oxidase \[[@R36]\]. It is important to note that endogenous antioxidants and repair capacity weaken with aging \[[@R32]\]. Among brain cells, neurons are particularly vulnerable to oxidative insults due to low levels of antioxidant enzymes, especially catalase (CAT) and glutathione peroxidase (GPX), and of nonenzymatic antioxidants, namely vitamin E and glutathione (GSH) \[[@R37]\].

In the CNS there are two major contrary acting neurotransmitters: the excitatory acting glutamate and the inhibitory acting γ-amino butyric acid (GABA). The excitatory glutamate, which could act toxically at higher concentrations, is thought to be one of the major contributors in oxidative stress development \[[@R38]\].

Oxidative stress is capable of damaging diverse cellular components or molecular targets, including nucleic acids, lipids, proteins, and carbohydrates \[[@R23]\]. Oxidation of monosaccharide sugars results in the formation of oxaldehydes, which can contribute to protein aggregation \[[@R39]\].

Free radicals may trigger disruption of nucleinic acids. They can break DNA strands or directly modify purine and pyridine bases, which leads to deletions and other mutations. DNA damage activates the DNA repair enzyme poly-ADP-ribose polymerase-1 (PARP-1), which overactivation depletes its substrate, nicotinamide adenine dinucleotide (NADH), slowing the rate of glycolysis, electron transport, and ATP formation, eventually leading to functional impairment or cell death \[[@R40]\]. There is also mtDNA, which is even more vulnerable target for free radical damage because of diminished repair mechanisms and lack of histones and due to its vicinity to the site of ROS generation. mtDNA disruption may lead to mitochondrial dysfunction resulting in disturbed cell function. Finally, RNA is the most susceptible to oxidative damage, since it is single stranded, not protected by hydrogen bonding, and less protected by proteins. RNA damages may result in altered proteins or dysregulation of gene expression \[[@R41]\]. One of mitochondrial disorders is the myoclonus epilepsy with ragged red fibers (MERRF) syndrome that is linked to point mutations in the mitochondrial tRNALys gene \[[@R42],[@R43]\]. Partial seizures are also frequently noticed in mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, which is associated with mutations in the mitochondrial tRNALeu gene \[[@R44],[@R45]\].

Polyunsaturated fatty acids in lipoproteins and phospholipids of biological membranes are also highly susceptible to oxidative damage, which leads to lipid peroxidation (LP). LP disrupts biological membranes and is thereby highly deleterious to their structure and function \[[@R46]\]. A large number of by-products are formed during this process, since unsaturated hydroperoxides generated by peroxidation of polyunsaturated fatty acids can break down to form different reactive aldehydes; the most known is malondialdehyde (MDA). Reactive aldehydes can bind covalently to proteins, thereby altering their function and inducing cellular damage \[[@R3]\].

Of particular importance is also protein redox state, as already described above in the section describing signalling roles of Ca^2+^ and ROS. Another possible consequence of increased ROS production is impairment of the Na^+^/K^+^-ATPase activity, which normally maintains ionic gradients of neuronal membranes. These chemical and electrical gradients generate the background for electrical activity, which is essential for normal nervous system functions. A decrease in Na^+^/K^+^-ATPase activity might decrease the convulsive threshold and therefore additionally lead to an increase in the release of excitatory neurotransmitters, such as glutamate and aspartate, or to a decrease of inhibitory neurotransmitters, such as GABA.

Glutamate is mainly present in the intracellular space. Increased glutamate concentration in the extracellular compartment can be toxic to neurons \[[@R47]\]. Increase in the extracellular concentration of glutamate in the case of CNS injury or disease has been linked to a number of potential mechanisms including excessive release and impaired cellular uptake. ROS generation can also support the induction of seizure activity by direct inactivation of glutamine synthetase (GS), thus permitting an excessive increase in glutamate. Excessive glutamate receptor activation caused either by glutamate or glutamate receptor agonists can induce neurotoxicity, which is described by the term excitotoxicity. This is manifested in excessive stimulation of glutamate receptors, namely NMDA (N-methyl-D-aspartate) and AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors, and an associated overwhelming increase in free cytosolic and mitochondrial Ca^2+^ concentration.

Sometimes Ca^2+^can reach high levels in neuronal cells already during the injury phase. It is anticipated that prolonged seizures, like status epilepticus, result in sufficient production of ROS to overwhelm the endogenous mitochondrial antioxidant defences \[[@R23]\].

More usually, during the injury phase, Ca^2+^ levels are insufficient to cause cell death. However, later during the latent phase, Ca^2+^ remains elevated and initiates many effects mediated by second messengers and consequently causes long lasting changes in neurons, including their death (see Fig. **[1](#F1){ref-type="fig"}**). If neuronal cells survive latent phase, Ca^2+^ still remains elevated during chronic phase and therefore plays unique role in maintaining spontaneous recurrent seizures \[[@R7]\].

Overall, all oxidative modiﬁcations may disturb the function of enzymes, receptors, neurotransmitters, and structural proteins, and therefore could contribute to progressive cell decline, aberrant neuroplasticity changes, and ultimately even cell death \[[@R23]\].

Mitochondrial Involvement
-------------------------

The main mitochondrial function is the production of cellular energy in the form of ATP by mitochondrial respiratory chain through oxidative phosphorylation by five multienzyme complexes located in the mitochondrial inner membrane \[[@R29]\]. Complexes I-IV are oxidoreductases which participate in the transfer of electrons from reduced substrates to oxygen and create an electrochemical proton gradient across the mitochondrial inner membrane. Complex V (ATP synthesis) couples proton reuptake with adenosine diphosphate (ADP) phosphorylation in the matrix to generate ATP \[[@R48]\] (Fig. **[2](#F2){ref-type="fig"}**). In addition to the energy production, mitochondria also play a crucial role in the maintenance of intracellular Ca^2+^ homeostasis, neurotransmitter biosynthesis, generation of ROS and mechanisms of cell death \[[@R48]\].

More recently, accumulating evidence suggests that mitochondria are also involved in acquired forms of epilepsy. Increase in mitochondrial oxidative stress and subsequent damage to cellular macromolecules have been demonstrated following repeated or prolonged seizures like status epilepticus and other injuries, such as hypoxic-ischemic insults, traumatic brain injury, or viral infection \[[@R23]\]. Impairment of mitochondrial function and increased ROS production has recently been demonstrated in human \[[@R49]-[@R51]\] and in several animal models of epileptic seizures \[[@R23],[@R52]-[@R54]\].

These changes strongly affect neuronal excitability and synaptic transmission, which is proposed to be highly relevant for seizure generation \[[@R3],[@R49]\]. Mitochondria could be involved in pathways leading to neuronal cell death, characteristic for the areas of epileptogenesis. Status epilepticus induced in experimental models by kainic acid or pilocarpine, are known to activate programmed cell death mechanisms \[[@R55]\]. Moreover, increased production of ROS is a feature of partially respiratory chain-inhibited mitochondria \[[@R56]\].

Mitochondrial proteins can be modified by carbonylation, nitration, S-glutathionylation, or S-nitrosylation. Function of many metabolic enzymes in the mitochondrial extracellular compartment, including ATPase, cytochrome c oxidase, NADH dehydrogenase, and NADH oxidase, can be consequently altered \[[@R57]\]. Oxidation of adenine nucleotide translocator (ANT) impairs the influx of adenosine diphosphate (ADP) into the matrix for ATP synthesis. Oxidation of manganese superoxide dismutase (MnSOD) can further compromise antioxidant capacity and lead to further oxidative stress \[[@R58]\]. Increased production of ROS directly down-regulates proteins of tight junctions and activates matrix metalloproteinases that contribute in the opening of the blood brain barrier \[[@R59]\]. This allows the entry of neurotoxins and inﬂammatory cells, which potentiates already existing oxidative stress.

Oxidative stress emerges as a common underlying cause of blood brain barrier dysfunction \[[@R60]\]. If disrupted, transport of molecules between blood and brain is altered in both directions. Increased oxidative mtDNA damage, mitochondrial hydrogen peroxide production, and alterations in the mitochondrial base excision repair pathway have been noted in the rat hippocampus after a period of three months following status epilepticus \[[@R15]\]. One of the consequences of oxidative damage is the release of mitochondrial cytochrome c into the cytosol, most probably by MPT pore. The MPT pore is an assembly of pre-existing proteins of the inner and outer mitochondrial membrane formed as a high conductance channel. It allows Ca^2+^ to be released from the mitochondria \[[@R61],[@R62]\]. MPT pore is formed by the apposition of the voltage-dependent anion channel (VDAC) in the outer membrane, the ANT in the inner membrane and the soluble matrix protein cyclophilin D \[[@R62]\]. The MPT pore is triggered by high Ca^2+^ concentration and other stimuli, including ROS, which may promote MPT pore by causing oxidation of thiol groups on the ANT. Likewise, ADP, reduced GSH, pyridine nucleotide pool, and acidic pH are all inhibitors of MPT opening \[[@R31]\].

Overall, as all other processes, also MPT triggering by ROS is potentiated by increased Ca^2+^. Ca^2+^is believed to be the coordinating signal to cytochrome c release. Bax, a proapoptotic member of the Bcl-2 family, interacts with MPT pore to induce permeability transition and cytochrome c release which is a key event in apoptosis \[[@R63]\]. Besides cytochrome c, opening of the MPT also leads to mitochondrial depolarization and loss of matrix solutes including GSH, ADP/ATP, etc. Cytochrome c released into the cytoplasm, further triggers the complex intrinsic mitochondrial pathway of apoptosis as shown in Fig. (**[2](#F2){ref-type="fig"}**). The cell death pathway may switch between apoptosis and necrosis, depending on the availability of intracellular ATP. Whereas apoptosis is the principal cell death pathway in the presence of sufficient ATP, overwhelming depletion of ATP results in necrotic cell death. In general, mitochondrial Ca^2+^ overload and consequent mitochondrial dysfunction appear to be combining factors in excitotoxicity. They are playing key roles in cell death \[[@R64]\].

Epileptic seizures can occur as a presenting sign of mitochondrial dysfunction in the central nervous system. This is seen in the occurrence of epileptic seizures in mitochondrial diseases arising from mutations in mtDNA or nuclear DNA \[[@R49]\]. In addition, systemic administration of mitochondrial toxins, such as 3-nitropropionic acid and cyanide, inhibits the functions of the mitochondrial respiratory chain that can compromise cellular energy metabolism and induce seizures in animal models \[[@R65],[@R66]\]. These accumulating evidences implicate that both, mtDNA mutations and exogenous mitochondrial toxins cause mitochondrial respiratory chain dysfunction which is associated with at least some of the mechanisms of epileptogenesis. Recently, evidence for a more general involvement of mitochondria, also in sporadic forms of epilepsy has been provided \[[@R67],[@R68]\]. Collectively, experimental and human epilepsy studies prove that mitochondria are intimately involved in pathways leading to neuronal cell death \[[@R49]\]. Therefore, increased mitochondrial oxidative stress and mitochondrial dysfunction may be the final common pathway that underlines all these neuropathological conditions and contributes to epileptogenesis \[[@R69]\]. In this way it could be capable of leading to chronic acquired epilepsies.

Mitochondrial dysfunction has gained considerable interest as a potential source of ROS and consequently a cause of epileptic seizures, especially in therapy-resistant forms of severe epilepsy.

Recent proteomic studies confirmed that certain mitochondrial components are altered following seizure activity and that brain injury may be explained by these alterations \[[@R70]\]. Hence, mitochondria can be considered as a target for potential neuroprotective strategies in epilepsy.

ANTIEPILEPTIC DRUG THERAPY AND OXIDATIVE STRESS
===============================================

Antiepileptic drugs (AEDs), at least in part, impair antioxidant systems. The ability of antioxidants to attenuate seizure generation and the accompanying changes in oxidative burden, further support an important role of antioxidants as having putative antiepileptic potential. Epilepsy is usually well controlled by presently available drugs. However, in 20 to 30% of patients seizures are not controlled with available medication. The majority of these patients suffer from focal form of epilepsy. The areas of epileptogenesis in these cases are usually characterised by cell loss. One of the most frequent and devastating forms of epilepsy involves the development of an epileptic focus in temporal lobe structures. While the granular cell layer is relatively preserved, the progressive loss of pyramidal cells of the CA1, CA3 and CA4 layers are the neuropathological hallmarks. Progressive cell loss is suggested to be a major reason why seizures of temporal lobe origin become particularly resistant to antiepileptic drug therapy at later stages of the disease \[[@R71]\].

Since antiepileptic treatment, to a various extent impairs the intrinsic ability to counteract oxidative stress by reducing endogenous antioxidants or increasing free radical production, progression of epilepsy was investigated in various clinical studies.

Influence of AEDs on Antioxidants and Markers of Oxidative Stress in Patients with Epilepsy
-------------------------------------------------------------------------------------------

The majority of oxidative stress measurements in patients with epilepsy have been performed on peripheral tissues, such as plasma, serum or red blood cells. However, oxidative stress may originate from various sources in the body and peripheral measurements might not necessarily accurately reflect the oxidative stress in the CNS. Nevertheless, studies on rat models of FeCl~3~/kainate brain injection induced seizures indicate that lipid peroxidation products were increased not only in the CNS, but also in blood \[[@R72],[@R73]\]. It should be mentioned that also the reverse situation is possible. In a study by Aytan *et al*., it has been established that peripheral oxidative stress can change oxidative status of CNS. In a rabbit model, feeding with high cholesterol diet caused an increase in serum MDA, which clearly correlated with an increase in protein oxidation parameters in the brain \[[@R74]\].

Increased activities of SOD \[[@R75],[@R76]\] and CAT \[[@R75],[@R77]\], and decreased activities of GPX \[[@R75],[@R78]\] and glutathione reductase (GR) \[[@R79]\] was observed in numerous studies in drug-naive patients with epilepsy. In a recent study, LP and percentage haemolysis in patients with epilepsy was higher compared to controls \[[@R79]\]. Furthermore, erythrocyte GR and plasma ascorbate and vitamin A concentrations were lower \[[@R79]\]. In the majority of these studies also increased markers of lipid peroxidation were noted \[[@R75],[@R77]-[@R82]\].

On the other hand, there are also studies, with very weak (unchanged SOD, CAT, GPX and GR activities) \[[@R78],[@R79],[@R82]-[@R84]\] or even opposite (decreased lipid peroxidation markers) \[[@R85]\] association of oxidative stress with epilepsy.

AEDs have diverse effects on the antioxidative system \[[@R86]-[@R88]\]. Some of them, especially from the older generation of AEDs (such as CBZ and VPA) may trigger oxygen-dependent tissue injury by several mechanisms \[[@R89]\]. Oxidative injury may play a role in the initiation and progression of epilepsy, therefore therapies aimed at reducing oxidative stress may ameliorate tissue damage and favourably alter the clinical course. Peroxidation of membrane lipids caused by an increase in generation of free radicals or decrease in the activities of antioxidant defence systems has been suggested to be critically involved in the seizure control.

Oxidative stress in patients with epilepsy treated with AEDs was assessed by measuring serum, plasma, erythrocyte, leukocyte or urine markers of macromolecular damage (MDA, RCD, P-SH, 8-OHdG, 15F-2t-isoP) and antioxidative enzyme activity (SOD, GPX, CAT, GR) (Table **[1](#T1){ref-type="table"}**).

The role of valproic acid (VPA) in exacerbation of oxidative stress is supported by reduced total antioxidant capacity (TAC) \[[@R86],[@R90]\] and enhanced total oxidative status (TOS) \[[@R90]\], reported for patients treated with VPA. Erythrocyte GPX \[[@R91],[@R92]\], GR \[[@R93]\] and serum Se \[[@R94]\], uric acid and albumin \[[@R80]\], which are considered endogenous enzymatic and non-enzymatic antioxidant molecules, were found to be reduced in children and adults treated with VPA. Furthermore, in studies in patients with epilepsy, treated with VPA, increased levels of oxidative macromolecular damage markers, such as MDA \[[@R76],[@R86],[@R90],[@R91]\] and 15F-2t-isoP \[[@R95]\], which are markers of enhanced lipid peroxidation and increased levels of 8-OHdG \[[@R90],[@R96]\], which is a marker of nucleic acid damage, were observed. Similarly, enhanced lipid peroxidation \[[@R80]\] and decreased SOD and GPX \[[@R92]\] was seen in studies with phenobarbital.

Elevated levels of lipid hydroperoxide were observed in phenytoin treated patients with epilepsy \[[@R88],[@R97]\]. Treatment with phenytoin was also associated with lower TAC and GSH. The role of carbamazepine (CBZ) in generating free radicals and consequently causing neuronal damage is not so evident. CBZ enhanced plasma LP in adolescent and adult patients \[[@R86]\] and caused marked increase in serum total peroxide levels in children \[[@R80]\]. Lower TAC \[[@R86]\] and GSH \[[@R98]\] in plasma, and GPX and CAT in erythrocytes were also observed \[[@R92]\]. In accordance with its pro-oxidative action, decreased SOD \[[@R92]\] and increased 8-OHdG \[[@R96]\] and nitrite/nitrate in erythrocytes were also observed. However, there are also studies which do not confirm CBZ pro-oxidative action \[[@R83],[@R86],[@R91],[@R95]\] and even studies with anti-oxidative action \[[@R88],[@R93],[@R99]\].

Long-term use of certain AEDs has been proposed to increase free radical formation and cause oxidative damage in neurons \[[@R90],[@R99],[@R110]\]. As demonstrated in Table **[1](#T1){ref-type="table"}**, this is particularly true for older AED generation, namely VPA, phenytoin and CBZ. Exacerbation of oxidative stress during treatment with AEDs could also be one of the reasons for pharmacotherapy resistant epilepsy. These pro-oxidative effects might lead to enhancement of seizure activity through increased hyperexcitability and/or the induction of neuronal damage, which can result in loss of AEDs efficacy or apparent functional tolerance and undesired side effects. Such functional tolerance may lead to complete loss of AED activity and cross-tolerance to other AEDs Tolerance develops to some AED effects much more rapidly than to others. It may lead to attenuation of side effects and also to loss of efficacy and is reversible after discontinuation of drug treatment \[[@R111]\]. Experimental evidence indicates that almost all first-, second-, and third-generation AEDs lose their antiepileptic activity during prolonged treatment, although to a different extent \[[@R111]\].

Many conventional anticonvulsants, namely phenobarbital, CBZ, and VPA are metabolized to generate reactive metabolites with capability of covalent binding to macromolecules \[[@R86],[@R112]\]. Therefore, the AEDs may not only suppress the epileptic seizures but also elicit systemic toxicity. There are at least two potential mechanisms by which the free radicals produced by oxidation of phenolic metabolites could lead to toxicity, by generating ROS and/or by covalent binding of their metabolic intermediates to proteins or other vital macromolecules \[[@R89],[@R112],[@R113]\].

Unfortunately, till now little is known about pro-oxidative or neuroprotective effects of newer second and third generation AEDs. Oxcarbazepine (OXC) and levetiracetam (LEV) are classified as newer, second generation AEDs \[[@R106]\]. As seen in the Table **[1](#T1){ref-type="table"}**, OXC antiepileptic actions could be due to its neuroprotective effects. Arhan *et al*. have shown that OXC decreases serum lipid peroxidation and nitrite/nitrate concentrations \[[@R101]\]. On the other hand, Ozden *et al*. found LEV to enhance lipid peroxidation \[[@R108]\]. To evaluate possible neuroprotective effects of newer AEDs more investigations need to be done in clinical practice on patients or on animal models.

Effects of AEDs on Oxidative Stress Markers in Different Animal Models of Seizures and Epilepsy
-----------------------------------------------------------------------------------------------

The generation of seizures is associated with changes in the intracellular levels of antioxidants and oxidants. Various experimental animal seizures models have been designed and investigated specifically for the evaluation of the role of various AEDs on modulating oxidative stress markers. The sites of seizure generation are not uniform in various models.

In numerous studies generation of free radicals was increased following pentylenetetrazol (PTZ) kindling, due to increased cytosolic Ca^2+^ concentrations. PTZ is best known for its use in screening antiepileptic drugs \[[@R104]\]. It is a tetrazole derivate with convulsant actions in mice, rats, cats, and primates, presumably by impairing GABA-mediated inhibition by action at GABA receptor. PTZ is considered a GABA antagonist.

Blood and brain toxicity after PTZ induced seizures and kindling were investigated in a rat model \[[@R125]\]. LP levels of plasma, erythrocyte, and brain cortex and brain microsomal fraction were increased by PTZ administration. Additionally, increased serum NO levels and accumulation of hydroxyl radicals were reported, while plasma and brain enzymatic and nonenzymatic antioxidants (GPX, vitamin E) were decreased.

Another often used model is pilocarpin induced model of seizures and epilepsy. Pilocarpine is a cholinergic agonist commonly used to induce seizures and an epilepsy-like status in rodents. The pilocarpin model of epilepsy relates both, to a model of acute induced seizures culminating with a prolonged episode of status epilepticus, as well as to a model of chronic spontaneous seizures \[[@R126]\]. During status epilepticus induced by pilocarpine in combination with lithium, hyper metabolism occurs with increased glucose consumption, which results in abnormal respiratory chain and neuronal damage \[[@R127]\]. As reported by Bellissimo *et al*., in pilocarpine model of epilepsy, in rats presenting status epilepticus or spontaneous seizures, decreased activity of SOD and increased levels of hydroperoxides in the hippocampus were observed \[[@R128]\]. To follow the evolution of neuronal damage caused by oxidative stress, cellular activation (investigated by fos protein expression and glucose utilization) and stress response (investigated by heat-shock protein (HSP72), immunoreactivity, and acid fuchsine staining) in lithium-pilocarpine seizure adult rat models of various duration, were analysed \[[@R129]\]. These investigations proved that regions with the largest metabolic activation coincided with the highest stress response and were consequently most heavily damaged \[[@R129]\].

In animal models of seizures and epilepsy, various AEDs were investigated. For instance, topiramate (TPM), is a voltage-gated Ca^2+^ channel inhibitor. The effects of TPM administration on pentylenetetrazol-induced rat model of seizures showed that lipid peroxidation levels in serum and kidneys and the nitric oxide levels in kidneys were decreased by TPM, while SOD and CAT activities in the kidneys were increased. GPX activity was not affected by pentylenetetrazol or TPM. It was concluded that TPM has protective effects on pentylenetetrazol-induced toxicity by inhibition of free radicals and by support of the antioxidant redox system \[[@R117],[@R119]\]. Many antiepileptic drugs have been investigated for their ability to attenuate the oxidative stress in animal models of seizures, the details of which are given in Table **[2](#T2){ref-type="table"}**.

Effects of AEDs on Markers of Oxidative Stress Studied *in vitro* in Primary Rat Astrocytes
-------------------------------------------------------------------------------------------

Astrocytes together with microglia constitute more than 90% of the total cell population in the adult brain. They are situated in key pivotal places in the CNS that might play an important role in epilepsy in several ways. They support neurons by providing different trophic factors \[[@R130]\]. It has been found that their function is not just to provide support to neurons, but also to play several other very important roles \[[@R131]\]. Astrocytes express receptors for different neurotransmitters \[[@R132]\]. For instance, they can respond to a local application of glutamate with a calcium elevation that travels as a wave \[[@R133]\]. These data suggest that astrocytes signal using spike-like calcium transients, which can travel over long distances and serve as a tool for neuron-astrocyte communication.

During normal brain function activity, astrocytes play a major role in the clearance of glutamate that is released from the nerve terminal into the extracellular space. Hence, when this astrocytes function is damaged, it may result in oxidative damage and associated epileptogenesis propagation or even its initiation. Therefore, studies on astrocytes might serve as a useful cell model to study the effects of AEDs on redox homeostasis.

Till now, only results from *in vitro* studies on primary rat astrocyte cell cultures are published \[[@R130],[@R134],[@R135]\]. Astrocytes have higher concentration of reduced glutathione and antioxidant enzymes. They pose glutamine synthetase, which is very sensitive to oxidative stress \[[@R35],[@R134]\]. On the other hand, it has been observed that in some pathological conditions astrocytes may contribute to neurological damage by increasing the production of ROS \[[@R35]\].

CBZ, OXC and TPM were demonstrated to initiate an oxidative process in primary cultures of rat cortical astrocytes. Both ROS and NO were shown to be involved (Table **[3](#T3){ref-type="table"}**). These results indicate that the newer, second generation AEDs change the examined metabolic activities to a much lesser extent, at least at therapeutic concentrations. Newer, second generation AEDs express neuroprotective effects on glial cells and, when used at an appropriate cell-specific concentrations, may be well tolerated by cortical astrocytes. Especially at higher AED concentrations, gabapentin (GBP), lamotrigine (LTG), tiagabine (TGB), and LEV seem to be better tolerated than are CBZ, TPM, and OXC. GBP, LTG, TGB, and LEV toxic effects on astrocytes were observed only at higher concentrations.

According to these findings, LEV and TGB may be considered as effective promising drugs in the treatment of epilepsy. However, a few other studies also claim a neuroprotective role for some older AEDs through antioxidative pathways. VPA for instance, was shown to be protective against oxidative stress in both, *in vitro* and *in vivo* models of epilepsy. It was suggested that VPA increases levels of glutathione \[[@R136],[@R137]\]. Thus, AEDs have been shown to contribute to both pro- and anti-oxidant activities. Their role in exacerbation of oxidative stress is still to be investigated.

CONCLUSION
==========

Since it has been shown that mitochondria are closely involved in pathways leading to neuronal cell death it seems reasonable to assume that mitochondrial dysfunction has a considerable role in epileptogenesis.

Additionally, ROS have an important role in cell signalling. Mitochondria are crucial players in maintaining cell Ca^2+^ homeostasis and serve as Ca^2+^ buffer. As a consequence of Ca^2+^influenced ATP production in the mitochondria, ROS are generated. It is proposed that Ca^2+^as well as ROS under physiological conditions work as a positive effectors and cellular signalling molecules, while their overload can lead to mitochondrial dysfunction, oxidative stress and cell damage.

Oxidative stress is considered one of the mechanisms that could independently contribute to the disease progression, in addition to serving as processes that underlie neuronal injury. It could also cause mitochondrial dysfunction, cell damage and consequently epilepsy, since neuronal dysfunction or death could serve as the propagating factor that may lead to the epileptic condition.

Various AEDs have diverse effects on the antioxidative system and some of them, especially from the older generation may trigger oxygen-dependent tissue injury by several mechanisms. Their influence on oxidative status in patients with epilepsy was extensively reviewed. Long-term use of certain AEDs has been proposed to increase free radical formation and cause oxidative damage in neurons. Furthermore AEDs pro-oxidative effects might lead to enhancement of seizure activity, which can result in loss of AEDs efficacy or apparent functional tolerance, pharmacotherapy resistance and undesired side effects. Convincing experimental evidence indicates that almost all first-, second-, and third-generation AEDs lose their antiepileptic activity during prolonged treatment, although to a different extent. Some reactive AED metabolites are capable of covalent binding to macromolecules and therefore not only suppress the epileptic seizures but also elicit systemic toxicity.

Since neuronal loss seems to be one of the major neurobiological abnormalities in the epileptogenic and epileptic brain, neuroprotective treatment during the epileptic process should result in milder structural damages, reduced epileptogenesis and less severe cognitive decline.

The latent period during the epileptogenesis, including the concept of ROS and Ca^2+^ crosstalk represents one of the more recent, still largely untapped potential, where targeted therapies could act to inhibit epileptogenesis, thereby preventing the development of acquired epilepsy. Recent studies have confirmed elevated Ca^2+^ during the injury phase. It remains significantly elevated in epileptogenesis and is chronically elevated in the chronic epilepsy phases of acquired epilepsy.

Nowadays, rapid and more precise discovery of possible causes and better understanding of underlying mechanisms of epileptogenesis opens up countless new possibilities for epilepsy therapy. Future is currently reflected in the design of AEDs with anticonvulsant and at the same time also neuroprotective activity. One of the potential mechanisms can be modulation of ROS - Ca^2+^ crosstalk.
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![A schematic presentation of proposed mechanism of cell damage and seizure generation in acquired epilepsy. Seizures or initial brain insult lead to accumulation of free radicals. Seizures alone, or through cell damage, cause hyperexcitability and increased extracellular glutamate concentration, which results through increased cytosolic Ca^2+^ concentration and consequently overstimulated Ca^2+^ signalling pathways in mitochondrial dysfunction, increased ATP consumption and energy depletion. This is associated with cell damage and necrotic or delayed apoptotic cell death. Cell death in itself is again considered as a cause of seizures. Beyond that, hyperexcitability may lead to lower seizure threshold, which can result in propagation reaction.](CN-10-328_F1){#F1}

![Assumed role of mitochondria, Ca^2+^, and ROS in neuronal excitotoxicity and epileptogenesis. After increase of mitochondrial Ca^2+^ inﬂux, mediated by various mechanisms, the generation of both ROS and RNS elicit downstream cell death signalling. The Ca^2+^ passage can lead to propagation and ampliﬁcation of mitochondrial Ca^2+^ overload. The mitochondrial respiratory chain is shown with complexes I, II, III, IV, and V. ROS and RNS can react with thiol groups (-SH) and subsequently cause opening of the MTP pore and Bax pore. One of the consequences is release of cyt-c across the outer membrane, which is the major initiation step in a cascade reaction of cell apoptosis. The cell death pathway may switch between apoptosis and necrosis, in relation to the intracellular ATP availability.\
Symbols legend:\
Ac-CoA: Acetyl coenzyme A; ANT: Adenine nucleotide translocase; Cyt-c: Cytochrome c; FADH~2~: Flavin adenine dinucleotide phosphate; GSH: Reduced glutathione; I--V: complexes I--V; MnSOD: Manganese superoxide dismutase; MPT: mitochondrial permeability transition; mtDNA: Mitochondrial deoxyribonucleinic acid; NAD: Nicotine adenine dinucleotide; NO: Nitric oxide; NOS: NO synthase; PARP: Poly-ADP-ribose polymerase; PBR: Peripheral benzodiazepine receptor; RNS: Reactive nitrogen species; ROS: Reactive oxygen species; VDAC: Voltage-dependent anion channel.](CN-10-328_F2){#F2}

###### 

Effects of Antiepileptic Drugs on Antioxidants and Oxidative Stress Markers in Blood of Patients with Epilepsy

  AED                                                         Findings       Materials              Subject                                                                     References
  -------------------- -------------------------------------- -------------- ---------------------- --------------------------------------------------------------------------- -------------------------
  **Valproic acid**    LP                                     ↑              Erc                    Childhood                                                                   \[[@R76], [@R99]\]
                       ↑                                      Plasma         Adolescent and adult   \[[@R86]\]                                                                  
                       ↑/-/-                                  Serum          Childhood              \[[@R90], [@R91], [@R100]\][\*](#T1F2){ref-type="table-fn"}/\[[@R101]\]     
  *(15F-2t-isoP)*      ↑                                      Urine          Childhood              \[[@R95]\]                                                                  
  8-OHdG               ↑                                      Serum          Childhood              \[[@R90]\]                                                                  
                       ↑                                      Leukocytes     Adult                  \[[@R96]\]                                                                  
  TAC                  ↓                                      Serum          Childhood              \[[@R90]\]                                                                  
                       ↓                                      Plasma         Adolescent and adult   \[[@R86]\]                                                                  
  TOS/XO               ↑/-                                    Serum          Childhood              \[[@R90]\]/\[[@R101]\]                                                      
  SOD                  ↓                                      Erc            Adult                  \[[@R92]\]/\[[@R98]\]                                                       
                       ↑/-                                    Erc            Childhood              \[[@R89], [@R91]\]/\[[@R100]\][\*](#T1F2){ref-type="table-fn"}              
                       \-                                     Plasma         Childhood              \[[@R102]\]                                                                 
  GPX                  -/↓                                    Erc            Adult                  \[[@R92]\]                                                                  
                       ↓/↑/↓[a](#T1F1){ref-type="table-fn"}   Erc            Childhood              \[[@R91], [@R99]\]/\[[@R93]\][\*](#T1F2){ref-type="table-fn"}/\[[@R100]\]   
                       ↑/-                                    Plasma/Serum   Childhood              \[[@R102]\]                                                                 
                       ↑                                      Plasma         Adolescent and adult   \[[@R86]\]                                                                  
  GR                   ↑[a](#T1F1){ref-type="table-fn"} /↓    Erc            Childhood              \[[@R100]\]/\[[@R93]\]                                                      
  Se                   -/↓[a](#T1F1){ref-type="table-fn"}     Plasma/Serum   Childhood              \[[@R99]\]/\[[@R94]\]                                                       
                       -/↑                                    Serum          Adolescent and adult   \[[@R86], [@R92]\]                                                          
  Nitrite/nitrate      ↑                                      Serum          Childhood              \[[@R103]\]                                                                 
  NO                   \-                                     Serum          Childhood              \[[@R86]\]                                                                  
  GSH                  ↓                                      Erc            Childhood              \[[@R100]\][\*](#T1F2){ref-type="table-fn"}                                 
                       \-                                     Plasma         Adult                  \[[@R98]\][\*](#T1F2){ref-type="table-fn"}                                  
  **Phenytoin**        LP                                     ↑/↑            Serum                  Adult/ Uncertain                                                            \[[@R88]\]^/^\[[@R97]\]
  TAC                  ↓                                      Serum          Uncertain              \[[@R97]\]                                                                  
  SOD                  ↑                                      Serum          Adult                  \[[@R88]\]                                                                  
  GSH                  ↓                                      Serum/Plasma   Adult                  \[[@R88]\]/\[[@R103]\][\*](#T1F2){ref-type="table-fn"}                      
  **Carbamazepine**    LP                                     ↑              Plasma                 Adolescent and adult                                                        \[[@R86]\]
  *(15F-2t-isoP)*      \-                                     Urine          Childhood              \[[@R95]\]                                                                  
  *(MDA)*              ↓                                      Erc            Childhood              \[[@R93]\]                                                                  
                       \-                                     Serum          Childhood              \[[@R104], [@R105]\]                                                        
  Total peroxide       ↑                                      Plasma         Childhood              \[[@R80]\]                                                                  
  8-OHdG               ↑                                      Leukocytes     Adult                  \[[@R96]\]                                                                  
  TAC                  ↓                                      Plasma         Adolescent and adult   \[[@R86]\]                                                                  
  SOD                  -/↓                                    Erc            Adult                  \[[@R92]\]                                                                  
                       ↑/-                                    Erc            Childhood              \[[@R89]\]/\[[@R88], [@R103], [@R106]\]                                     
  **Carbamazepine**                                           ↑              Serum                  Adult                                                                       \[[@R88]\]
  GPX                  -/↓                                    Erc            Adult                  \[[@R92]\]                                                                  
                       ↑/-                                    Erc            Childhood              \[[@R93], [@R106]\][\*](#T1F2){ref-type="table-fn"}                         
                       \-                                     Plasma         Adolescent and adult   \[[@R86]\]                                                                  
  CAT                  ↓                                      Erc            Adult                  \[[@R92]\]                                                                  
  Se                   \-                                     Erc/Plasma     Adolescent and adult   \[[@R86], [@R92]\]                                                          
  Nitrite/nitrate      ↑                                      Serum          Children               \[[@R103]\]                                                                 
  GSH                  ↓                                      Erc            Childhood              \[[@R100]\][\*](#T1F2){ref-type="table-fn"}                                 
                       ↓                                      Plasma         Adult                  \[[@R98]\][\*](#T1F2){ref-type="table-fn"}                                  
  **Phenobarbital**    Lipid hydroperoxide                    ↑              Plasma                 Childhood                                                                   \[[@R80]\]
  SOD/GPX              ↓                                      Erc            Adult                  \[[@R92]\]                                                                  
  GPX/GR               -/↑                                    Plasma         Childhood/Adult        \[[@R79], [@R107]\]/\[[@R35]\]                                              
  **Levetiracetam**    8-OHdG                                 \-             Leukocytes             Adult                                                                       \[[@R96]\]
  LP *(15F-2t-isoP)*   ↑                                      Urine          Adult                  \[[@R108]\]                                                                 
  **Oxcarbazepine**    LP / Nitrite/nitrate                   ↓/↓            Serum                  Childhood                                                                   \[[@R86]\]
  GPX/SOD              -/-                                    Erc            Adults                 \[[@R109]\]                                                                 

Only in patients with a severe adverse effect related to valproic acid therapy

Healthy control

↓ decreased; ↑ increased; - no significant changes observed; CAT: Catalase; Erc: Erythrocytes; GPX: Glutathione peroxidase; GR: Glutathione reductase; GSH: Glutathione; LP -- Lipid peroxidation; MDA: Malondialdehyde; NO: Nitric oxide; SOD: Superoxide dismutase; TAC: Total antioxidant capacity; TOS: total oxidative status; 8-OHdG: 8-hydroxydeoxyguanosine; 15F-2t-isoP: 15-F(2t)-isoprostane.

###### 

Effects of Antiepileptic Drugs on Oxidative Stress Markers in Various Animal Models of Seizures and Epilepsy

  AED                 Animals       Model                                  Marker                                             Findings           Materials                      References
  ------------------- ------------- -------------------------------------- -------------------------------------------------- ------------------ ------------------------------ --------------------------
  **Valproic acid**   Rats          Pilocarpine                            CAT/NO                                             ↓                  Brain                          \[[@R114]\]
                                    GSH                                    \-                                                                    \[[@R114]\]                    
                                    Lipid peroxidation (MDA)               \-                                                                    \[[@R114]\]                    
                      PTZ-kindled   TAC/GSH/NO                             ↓/↑/-                                              Brain              \[[@R105]\]                    
  **Carbamazepine**   Mice          PTZ-kindled                            SOD/ CAT/GSH/ Lipid peroxidation (MDA)             \-                 Brain                          \[[@R115]\]
  **Trimetazidine**   Mice          PTZ-kindled                            GSH                                                ↑                  Brain                          \[[@R116]\]
                                    Lipid peroxidation (MDA)               ↓                                                                     \[[@R116]\]                    
  **Topiramate**      Rats          PTZ-induced                            GPX                                                ↑/-                Erythrocytes                   \[[@R117]\]/ \[[@R118]\]
                                                                           -/↑                                                Brain microsomal   \[[@R117]\]                    
                                                                           \-                                                 Brain cortex       \[[@R81], [@R117], [@R119]\]   
                                    GSH                                    ↑↑                                                 Erythrocytes       \[[@R117]\]                    
                                                                           ↑                                                  Brain cortex       \[[@R81], [@R117], [@R119]\]   
                                                                           ↑↑↑/↑↑                                             Brain microsomal   \[[@R81], [@R117], [@R119]\]   
                                    Lipid peroxidation                     ↓?-/↓                                              Erythrocytes       \[[@R117]\]/ \[[@R118]\]       
                                                                           ↓↓                                                 Brain cortex       \[[@R81], [@R117], [@R119]\]   
                                                                           ↓                                                  Brain microsomal   \[[@R81], [@R117], [@R119]\]   
  Mice                PTZ-kindled   SOD/CAT/GSH/Lipid peroxidation (MDA)   -/-/↓/↑                                            Brain              \[[@R120]\]                    
  **Levetiracetam**   Mice          Pilocarpin                             CAT/GSH/Lipid peroxidation (MDA)/Nitrite:Nitrate   ↓/↑/↓/↓            Brain (hippocampus)            \[[@R121]\]
  **Lamotrigine**     Mice          PTZ-kindled                            SOD/CAT/GSH/Lipid peroxidation (MDA)               ↑/↑/↑/↓            Brain                          \[[@R115]\]
                                    SOD/CAT/GSH/Lipid peroxidation (MDA)   -/-/↓/↓                                            Brain              \[[@R120]\]                    
  **Oxcarbazepine**   Mice          PTZ-kindled                            SOD/CAT/GSH/Lipid peroxidation (MDA)               -/-/↓/↑            Brain                          \[[@R120]\]
  **Phenytoin**       Rats          Iron induced                           Lipid peroxidation                                 \-                 Brain                          \[[@R122]\]
  **Zonisamide**      Rats          Iron induced                           Lipid peroxidation (MDA)                           ↓                  Brain cortex                   \[[@R118], [@R123]\]
                                    8-OHdG                                 ↓                                                  Brain              \[[@R124]\]                    

↓ decreased; ↓↓ moderately decreased; ↑ increased; ↑↑ moderately increased; ↑↑↑ strongly increased; - no significant changes observed; ?- unclear influence; CAT: Catalase; GPX: Glutathione peroxidase; GR: Glutathione reductase; GSH: Glutathione; MDA: Malondialdehyde; NO: Nitric oxide; PTZ: Pentylenetetrazol; SOD: Superoxide dismutase; TAC: Total antioxidant capacity; 8-OHdG: 8-hydroxydeoxyguanosine.

###### 

Effects of Therapeutic Concentrations of Antiepileptic Drugs on Primary Rat Astrocytes *in vitro*

  AED                          Ref. range (mg/L)   Conc. (mg/L)   C. viability (MTT)   C. toxicity (LDH)   GS   ROS   MDA   NO
  ---------------------------- ------------------- -------------- -------------------- ------------------- ---- ----- ----- ----
  **First-generation AEDs**                                                                                                 
  **Carbamazepine**            4-12                10             ↓↓                   ↑                   ↓    ↑↑    ↑↑    ↑↑
  **Second-generation AEDs**                                                                                                
  **Gabapentin**               2-20                10             \-                   \-                  \-   \-    ↑     ↑↑
  **Lamotrigine**              2,5-15              10             \-                   \-                  \-   ↑     ↑     ↑↑
  **Levetiracetam**            12-46               10             \-                   \-                  \-   ↑     \-    
                                                   50             ↓                    ↑                   ↓    ↑↑    ↑     ↑
  **Oxcarbazepine**            3-3,5               1              ↓                    ↑                   ↓    ↑     ↑     ↑
                                                   10             ↓↓                   ↑↑                  ↓    ↑↑    ↑↑    ↑↑
  **Tiagabine**                5-20                10             \-                   \-                  \-   ↑     ↑     \-
  **Topiramate**               5-20                10             ↓                    ↑↑                  ↓    ↑↑    ↑↑    ↑↑

Adapted from Pavone *et al*. \[[@R130]\]

↓ slightly decreased; ↓↓ moderately decreased; ↑ slightly increased; ↑↑ moderately increased (p \< 0.01); - no significant changes observed (p \> 0.01); LDH: Lactic dehydrogenase; GPX: Glutathione peroxidase; GS: Glutathione synthetase; MDA: Malondialdehyde; MTT: tetrazolium salt test; NO: Nitric oxide; ROS: Reactive oxygen species.
